JP2013508288A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508288A5
JP2013508288A5 JP2012534357A JP2012534357A JP2013508288A5 JP 2013508288 A5 JP2013508288 A5 JP 2013508288A5 JP 2012534357 A JP2012534357 A JP 2012534357A JP 2012534357 A JP2012534357 A JP 2012534357A JP 2013508288 A5 JP2013508288 A5 JP 2013508288A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound
pharmaceutically acceptable
prodrug
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012534357A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508288A (ja
JP5758395B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052674 external-priority patent/WO2011047156A1/en
Publication of JP2013508288A publication Critical patent/JP2013508288A/ja
Publication of JP2013508288A5 publication Critical patent/JP2013508288A5/ja
Application granted granted Critical
Publication of JP5758395B2 publication Critical patent/JP5758395B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012534357A 2009-10-15 2010-10-14 疼痛を治療するためのセピアプテリンレダクターゼ阻害薬 Expired - Fee Related JP5758395B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25201309P 2009-10-15 2009-10-15
US61/252,013 2009-10-15
PCT/US2010/052674 WO2011047156A1 (en) 2009-10-15 2010-10-14 Sepiapterin reductase inhibitors for the treatment of pain

Publications (3)

Publication Number Publication Date
JP2013508288A JP2013508288A (ja) 2013-03-07
JP2013508288A5 true JP2013508288A5 (enExample) 2013-12-05
JP5758395B2 JP5758395B2 (ja) 2015-08-05

Family

ID=43876540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534357A Expired - Fee Related JP5758395B2 (ja) 2009-10-15 2010-10-14 疼痛を治療するためのセピアプテリンレダクターゼ阻害薬

Country Status (6)

Country Link
US (2) US9169234B2 (enExample)
EP (1) EP2488025A4 (enExample)
JP (1) JP5758395B2 (enExample)
AU (1) AU2010306750B2 (enExample)
CA (1) CA2777782C (enExample)
WO (1) WO2011047156A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850324A (zh) 2006-08-07 2013-01-02 硬木药品公司 吲哚化合物
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
CN102329263A (zh) * 2011-10-17 2012-01-25 上海化学试剂研究所 一种n-乙酰基-5-甲氧基色胺的制备方法
US9730447B2 (en) 2013-04-15 2017-08-15 E I Du Pont De Nemours And Company Fungicidal amides
WO2015071230A1 (en) * 2013-11-15 2015-05-21 Bayer Cropscience Ag Catalytic hydrogenation of nitriles
EP3213062B1 (en) * 2014-10-31 2020-02-12 Children's Medical Center Corporation Methods and assays relating to sepiapterin reductase inhibition
CA3038280A1 (en) 2015-09-30 2017-04-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. - Generalverwaltung Heteroaryl derivatives as sepiapterin reductase inhibitors
CA3011423C (en) * 2016-01-26 2022-01-18 Ahmet Hacimuftuoglu N3,n6-bis(2-(5-methoxy-1h-indole-3-yl)ethyl)-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxamide and use thereof in the field of neurotoxicity
US20170291372A1 (en) * 2016-04-09 2017-10-12 Velo3D, Inc. Generating three-dimensional objects by three-dimensional printing with rotation
NZ745936A (en) 2016-04-27 2020-02-28 Univ Puerto Rico 1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases
MX2019007640A (es) 2016-12-21 2019-09-06 Bayer Cropscience Ag Hidrogenacion catalitica de nitrilos.
WO2019175332A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4 pathway inhibition and use thereof for treating t-cell mediated autoimmune diseases or hypersensitivity
CN108689856A (zh) * 2018-07-09 2018-10-23 上海华堇生物技术有限责任公司 一种3-羟基-β-硝基苯乙烯的新制备方法
US10720217B1 (en) * 2019-01-29 2020-07-21 Silicon Storage Technology, Inc. Memory device and method for varying program state separation based upon frequency of use
JP7611900B2 (ja) 2020-04-14 2025-01-10 日産化学株式会社 縮合複素環化合物
WO2022104475A1 (en) 2020-11-19 2022-05-27 Magicmed Industries Inc. Nitrilated psilocybin derivatives and methods of using
CN117597329A (zh) * 2021-05-05 2024-02-23 凯尔化学科技公司 催化色胺方法及前体
CN113214133B (zh) * 2021-05-08 2023-03-07 河北维达康生物科技有限公司 一种褪黑素的合成方法
CN113960317A (zh) * 2021-08-19 2022-01-21 深圳市辅酶医科技有限公司 一种测量生物样品中nad+浓度的生物传感器及方法
CN113788780B (zh) * 2021-10-15 2023-06-16 河北维达康生物科技有限公司 一种n-乙酰基-5-甲氧基色胺的合成方法
WO2024008341A1 (en) 2022-07-08 2024-01-11 Institut Curie Serotonin analogues for use in treating metalloptosis-associated disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437398A1 (fr) * 1978-06-20 1980-04-25 Commissariat Energie Atomique Compose iode utilisable comme traceur en radio-immunologie
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
KR100362864B1 (ko) 1994-02-22 2003-04-16 메렐 파마슈티칼스 인크. 에스트로겐관련신생물및질환의치료에유용한신규인돌유도체
CN100441574C (zh) * 1996-03-08 2008-12-10 武田药品工业株式会社 三环化合物及其制备和用途
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
US6306890B1 (en) * 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US6448281B1 (en) * 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
AU2002344820B2 (en) * 2001-06-20 2006-12-14 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment of diabetes
PT1451154E (pt) * 2001-12-03 2008-04-21 Wyeth Corp Inibidores de fosfolipase a2 citossólica
DE10252665A1 (de) * 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
US7084154B2 (en) 2003-02-11 2006-08-01 Pharmacopeia Drug Disclovery, Inc. 2-(aminomethyl) arylamide analgesics
US7906520B2 (en) * 2003-11-13 2011-03-15 The General Hospital Corporation Methods for treating pain
US7074775B2 (en) * 2004-09-14 2006-07-11 Miller Landon C G Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
JP5197014B2 (ja) 2004-12-10 2013-05-15 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ ヒストンデアセチラーゼ（ｈｄａｃ）阻害剤としての複素環誘導体
WO2007006739A1 (en) * 2005-07-12 2007-01-18 Bayer Cropscience Sa Benzoheterocyclylethylcarboxamide derivatives
KR20080035683A (ko) 2005-08-10 2008-04-23 노파르티스 아게 데아세틸라제 억제제의 사용 방법
US7902251B2 (en) * 2005-10-19 2011-03-08 Allergan, Inc. Method for treating pain
BRPI0619096A2 (pt) * 2005-12-01 2011-09-13 Hoffmann La Roche derivados de ácidos vinìlogos
JP5142513B2 (ja) * 2005-12-05 2013-02-13 大塚製薬株式会社 医薬
DK1957073T3 (da) 2005-12-05 2014-05-12 Otsuka Pharma Co Ltd Lægemiddel
JP5089185B2 (ja) * 2006-02-02 2012-12-05 大塚製薬株式会社 コラーゲン産生抑制剤。
FR2898358B1 (fr) * 2006-03-08 2008-05-30 Macef Sa Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux
RU2303597C1 (ru) * 2006-05-12 2007-07-27 Иващенко Андрей Александрович Фармацевтическая композиция, способы ее получения и применения
US20080009485A1 (en) * 2006-05-26 2008-01-10 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis
US7893055B2 (en) * 2006-06-28 2011-02-22 Bristol-Myers Squibb Company HIV integrase inhibitors
AU2007271964B2 (en) 2006-07-14 2012-01-19 Novartis Ag Pyrimidine derivatives as ALK-5 inhibitors
CN102850324A (zh) 2006-08-07 2013-01-02 硬木药品公司 吲哚化合物
JP2008115175A (ja) * 2006-10-13 2008-05-22 Otsuka Pharmaceut Co Ltd 複素環化合物
WO2008047883A1 (en) 2006-10-13 2008-04-24 Otsuka Pharmaceutical Co., Ltd. Piperazine-substituted benzothiophenes for treatment of mental disorders
FR2907451B1 (fr) * 2006-10-18 2008-12-12 Servier Lab "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
JP5399262B2 (ja) 2006-12-08 2014-01-29 エグゼリクシス パテント カンパニー エルエルシー Ｌｘｒおよびｆｘｒのモジュレーター
US20080287452A1 (en) * 2007-05-16 2008-11-20 Wyeth Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
TW200914437A (en) 2007-06-20 2009-04-01 Ironwood Pharmaceuticals Inc FAAH inhibitors
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
GB0910003D0 (en) * 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2013508288A5 (enExample)
JP2013544860A5 (enExample)
JP2013537203A5 (enExample)
JP2012532848A5 (enExample)
JP2013540713A5 (enExample)
JP2015504067A5 (enExample)
JP2014508811A5 (enExample)
JP2016503793A5 (enExample)
JP2014520898A5 (enExample)
JP2015509098A5 (enExample)
JP2013510120A5 (enExample)
JP2013531031A5 (enExample)
JP2015501833A5 (enExample)
ME02322B (me) Kinazni inhibitor koji reguliše signalni put apoptoze
JP2014515351A5 (enExample)
WO2012099942A3 (en) Methods and compositions for treating metabolic syndrome
JP2014508753A5 (enExample)
JP2016503797A5 (enExample)
JP2013542261A5 (enExample)
JP2011504903A5 (enExample)
WO2012054535A3 (en) Compounds, compositions and methods useful for cholesterol mobilisation
JP2012505855A5 (enExample)
JP2014505107A5 (enExample)
JP2016507575A5 (enExample)
WO2010065512A3 (en) Compounds for treating proliferative disorders